Serina Therapeutics Statistics
NYSE: SERHealth CareBiotechnology: Pharmaceutical PreparationsUSD
1.12-0.08 (-6.67%)
At close: Nov 20, 3:59 PM ET · Delayed 15 min
Serina Therapeutics by the numbers
Serina Therapeutics has a market capitalization of $29.8 million based on 26.57M shares outstanding. With trailing EPS of $-1.63, Serina Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 38.4% below its 50-day average and 43.6% below its 200-day average.
Average daily trading volume is 68.98K shares, or about $77,262 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
SER valuation vs. peer median
| Metric | SER | Peer median | Difference |
|---|---|---|---|
| Market cap | $29.76M | $29.10M | +2% |
| Avg. volume | 68.98K | 153.03K | -55% |
Peer median across 8 companies: NXTC, NNVC, RNTX, ATHE, AYTU, PMN, FLNA, GRDX.
Valuation
- Market cap
- $29.76M
- Price / sales (latest FY)
- 228.91
- EPS (TTM)
- $-1.63
- Shares outstanding
- 26.57M
Price and trading
- Previous close
- 1.20
- Open
- 1.16
- Day range
- 1.06 – 1.26
- 52-week range
- 1.06 – 4.26
- 52-week change
- -71.93%
- Beta
- —
- Volume
- 62.15K
- Average volume
- 68.98K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 26, 2026
Additional statistics
- Market Cap
- 29.76M
- Forward Pe
- -1.07
- Eps
- -1.63
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 4.26
- Week52 Low
- 1.06
- Avg Volume
- 68,984.00
- Shares Outstanding
- 26.57M
- Ma50
- 1.82
- Ma200
- 1.98
- Earnings Date
- Nov 26, 2026
- Pct From52w High
- -73.71%
- Pct From52w Low
- 5.66%